(Credit-Canva)
Weight loss is usually considered a good thing, unexpected and extreme weight loss can be a sign of something in your body going very wrong. There could be some underlying issues that are causing your body to pull weight and nutrition from your muscles and body fat to keep you going. As you grow old, your limbs grow weaker, and same for your muscles, so you do lose some weight as you age, but losing a lot of it too quickly could be a sign of something much worse, Dementia. A recent study published in JAMA Network Open 2025 Cardiometabolic Trajectories Preceding Dementia in Community-Dwelling Older Individuals, has identified potential early indicators of dementia, including significant weight loss and specific digestive changes, appearing years before noticeable cognitive decline.
The study showed that people who later got dementia had their Body Mass Index, or BMI, go down faster than those who stayed healthy. BMI is a way to see if someone's weight is healthy for their height. This drop in BMI started happening many years before they were told they had dementia, sometimes as early as 11 years ago. Also, these people often started with a lower BMI to begin with. So, even though everyone's weight might change a little as they get older, the people who developed dementia had a much bigger and faster weight loss.
Along with their BMI, the size of their waist also changed. People who ended up with dementia had smaller waist sizes, and this difference was noticeable about 10 years before they were diagnosed. This means that their bodies were changing in ways that showed up long before they or their doctors noticed any problems. So, not only was there weight loss, but also a loss of abdominal fat. This measurement is important because fat around the waist can be related to other health issues.
The study also found changes in their blood. Specifically, the "good" cholesterol, called HDL, went up in people who developed dementia. This increase happened about five years before they were diagnosed. It's tricky because HDL is usually seen as a good thing for your heart. But in this case, it seems like it might be a sign of changes happening in the brain. Scientists are still trying to understand why this happens.
When we see that people with dementia lose weight, it's easy to think that the weight loss is what caused dementia. But experts think it's the other way around. They call this "reverse causation." This means that the brain changes that cause dementia also cause people to lose weight. The brain changes can affect things like appetite, how the body uses food, and how people go about their daily lives. For example, people might forget to eat, have trouble making meals, or move around less.
While the study revealed a lot about different indicators of dementia and bodily changes, there are many limitations to the study. Everyone loses some weight as they get older. So, it's hard to know when weight loss is just a normal part of aging and when it's a sign of dementia. The study found that people with dementia lost weight faster, but it's still tricky to tell the difference in everyday life. Doctors need to look at other things, like memory tests, to figure out if someone's weight loss is a cause for concern.
If someone is losing weight without trying, and they're also having problems with their memory or thinking, it's important to talk to a doctor. It's not just about the weight loss; it's about the whole picture.
Credit: iStock
When you hear the term plastic surgery, what comes to mind first? For many people, it's cosmetic enhancements such as facelifts, rhinoplasty, or body contouring. However, experts say this is one of the biggest misconceptions about the specialty.
Marking World Plastic Surgery Day on July 15, specialists highlighted that plastic surgery is far more than improving appearance. While cosmetic surgery focuses on enhancing aesthetics, reconstructive plastic surgery is dedicated to restoring form and function after injuries, burns, cancer, or congenital conditions.
Originally launched as National Plastic Surgery Day by the Association of Plastic Surgeons of India (APSI) in 2011, the observance was adopted globally by international plastic surgery societies in 2021.
The theme for World Plastic Surgery Day 2026 is "Changing Lives with Plastic and Reconstructive Surgery."
Speaking to HealthandMe, Dr. Deepak K. L. Gowda, Senior Consultant – Aesthetics, Plastic Surgery & Reconstructive Surgery at SPARSH Hospital, said plastic surgery is a broad medical specialty, while cosmetic surgery is only one of its subspecialties.
Cosmetic surgery is performed to improve the appearance of otherwise healthy and functional body structures. Reconstructive plastic surgery, on the other hand, aims to restore appearance and function following injury, disease, cancer surgery, burns, or congenital defects.
According to Dr. Gowda, reconstructive procedures account for more than 75% of plastic surgery practice, while cosmetic procedures make up a comparatively smaller proportion. However, the growing popularity of aesthetic treatments has led many people to wrongly assume that plastic surgery is only about beauty enhancement.
Cosmetic surgery is designed to enhance physical appearance in individuals whose body structures function normally. Some of the most commonly performed procedures include: breast augmentation, rhinoplasty (nose reshaping), facelifts
and dermal fillers and more.
Reconstructive plastic surgery helps restore both appearance and function after illness, injury, or trauma. Common procedures include:
Dr. Chintan Gujarati, Cosmetic and Plastic Surgeon at Ruby Hall Clinic, told HealthandMe that cosmetic procedures can enhance appearance and boost confidence, but they should always be approached with careful planning and informed decision-making.
He recommended asking these seven questions before undergoing any cosmetic procedure:
1. Is the procedure right for me?
Discuss whether the treatment is suitable for your health, goals, and individual needs.
2. Is my surgeon qualified?
Ensure the procedure is performed by a board-certified plastic surgeon or a trained specialist with relevant experience.
3. What are the risks?
Understand possible complications, including infection, scarring, or the need for additional treatment.
4. What results can I realistically expect?
Cosmetic procedures can improve appearance, but they cannot guarantee perfection.
5. What is the recovery process?
Ask about downtime, pain management, activity restrictions, and when you can safely return to your routine.
6. What will the procedure cost?
Request a detailed breakdown covering consultation fees, hospital charges, medications, and follow-up visits to avoid unexpected expenses.
7. What if I am unhappy with the results?
Discuss revision policies and available corrective options before making a decision.
Making an Informed Decision
Experts emphasized that choosing to undergo a cosmetic procedure is a personal decision that should be based on realistic expectations, qualified medical advice, and a clear understanding of the benefits, risks, recovery process, and overall costs.
They also stress that plastic surgery extends well beyond aesthetics, with reconstructive surgery continuing to play a vital role in restoring both function and quality of life for patients affected by injury, disease, or congenital conditions.
Credit: AI
A new study has found that muscle health may be just as important as body weight in determining a person's risk of developing type 2 diabetes, highlighting the need to look beyond the number on the scale.
The research, led by Curtin University in Australia found that people with both excess body fat and low muscle mass faced a significantly greater risk of developing type 2 diabetes than those who had obesity alone. The findings said that building and preserving muscle mass could become key in diabetes prevention.
The researchers studied data from thousands of adults to examine how body composition shapes type 2 diabetes risk. Participants were grouped based on levels of body fat and muscle mass, allowing scientists to compare how different combinations affected the chances of developing the disease.
Individuals with both high body fat and poor muscle health were more prone to type 2 diabetes compared to people who were obese but maintained healthier muscle mass.
According to the researchers, the findings confirm that muscle tissue plays a vital role in regulating blood sugar because it is one of the body's primary sites for glucose storage and use.
"Most people know carrying excess weight can increase the risk of type 2 diabetes, but our findings show muscle health is also an important piece of the puzzle," said lead researcher Mr. Guan. "People with both excess body fat and low muscle mass had a substantially higher risk of developing type 2 diabetes than those with obesity alone."
He added, "This suggests we need to look beyond the number on the scales when assessing diabetes risk, as maintaining muscle strength and muscle mass may be just as important as managing body weight."
Also read: Wegovy More Likely To Cause Rare Blindness Than Ozempic And Other Similar Drugs, Recent Study Finds
The study also sheds light on sarcopenic obesity, a condition characterized by excess body fat combined with reduced muscle mass or muscle function. Researchers say this condition is often overlooked because many people appear to have only obesity, while declining muscle health remains undetected.
Experts believe the findings indicate that rather than relying solely on body mass index (BMI), experts must assess muscle mass and strength when identifying patients at high risk for diabetes. This can help prevent the disease early.
The research also supports current public health recommendations that say resistance training alongside aerobic exercise is crucial.
Strength training helps preserve and build muscle mass while improving insulin sensitivity, making it an important component of diabetes prevention. Combined with adequate protein intake and healthy weight management, maintaining muscle health may significantly reduce long-term metabolic risk.
Type 2 diabetes is a metabolic disorder in which the body fails to utilize insulin. Frequently associated with obesity, a diet lacking in nutritious foods, and physical inactivity can lead to this diagnosis, It affects hundreds of millions of people worldwide and continues to rise alongside increasing rates of obesity and physical inactivity.
Credit: iStock
In a global first, India's drug regulator has approved a fully synthetic cannabidiol (CBD) therapy for the treatment of mild to moderate anxiety disorders, marking a significant milestone in cannabinoid-based medicine.
The Central Drugs Standard Control Organisation (CDSCO) has granted regulatory approval to Zenara Pharma, the manufacturing partner of Leiutis Pharmaceuticals, to produce a synthetic cannabidiol oral solution (150 mg/ml). The prescription-only therapy is intended to be used alongside cognitive behavioural therapy (CBT) for managing mild to moderate anxiety disorders.
In a statement, Leiutis Pharmaceuticals said the approval follows a successful Phase III clinical trial conducted in India under CDSCO guidelines. A Phase IV post-marketing study will now be carried out to further evaluate the therapy.
Leiutis noted that "this is the first regulatory approval anywhere in the world for a fully synthetic cannabidiol oral solution for anxiety disorders".
K. Chandrasekhar, CEO and Managing Partner of Leiutis Pharmaceuticals LLP, said the approval is the result of nearly a decade of cannabinoid research, including the development of a proprietary synthetic cannabinoid manufacturing process, novel drug-delivery technology, and extensive preclinical and clinical studies.
“Developed entirely in India and protected by patents in key markets, this approval is a significant milestone for our innovation pipeline, paving the way for next-generation cannabinoids. We thank the Government of India, clinical investigators, researchers and study participants who made it possible,” Chandrasekhar said.
The newly approved medicine contains a fully synthetic cannabidiol (CBD) active pharmaceutical ingredient (API), meaning no cannabis plant material is used in its production.
The therapy combines:
Biophore has also filed a United States Drug Master File (US DMF) for the synthetic CBD manufacturing process, reflecting internationally recognized quality standards.
The approval comes at a time when anxiety disorders are rising sharply in India. According to a recent analysis from the Global Burden of Disease Study published in The Lancet, anxiety disorders in India increased by 123.5% between 1990 and 2023.
The prevalence rose from 2,591.9 cases per lakh population in 1990 to 5,792.8 cases per lakh in 2023, driven largely by increasing rates of anxiety and depression.
Cannabidiol (CBD) is one of the naturally occurring compounds found in hemp and cannabis plants. Unlike THC, it does not produce intoxicating effects.
CBD has been studied for several potential therapeutic uses, including:
The newly approved product, however, uses synthetic CBD, which is produced entirely in a laboratory rather than extracted from the cannabis plant. Synthetic CBD offers a highly consistent and contaminant-free formulation, helping standardize dosing and quality.
CBD already has established medical use in certain seizure disorders in some countries and continues to be investigated for a range of other conditions, including anxiety, chronic pain, inflammation and schizophrenia.
CBD is generally well-tolerated, but some users may experience mild side effects like drowsiness, reduced appetite, or diarrhea. Side effects are often due to interactions with other medications.
© 2024 Bennett, Coleman & Company Limited